Apellis Pharmaceuticals recently presented at the 44th Annual J.P. Morgan Healthcare Conference, outlining 2025 performance ...
Apellis Pharmaceuticals (NASDAQ:APLS) used its presentation at the 44th Annual JPMorgan Healthcare Conference to outline its ...
The move comes in response to increasing delivery demands for GLP-1s, plus broader conversations about pharmaceutical ...
Becton, Dickinson and Co. will invest more than $110M to expand a Nebraska syringe facility, add 120 jobs and support ...
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Prefilled Syringes in 2017 & Beyond" report to their offering. The administration of therapeutic drugs via injection is ...
Please provide your email address to receive an email when new articles are posted on . The prefilled syringe is indicated for wet age-related macular degeneration, diabetic macular edema and retinal ...
Pharmaceutical Technology on MSN
BD invests $110m to expand US prefillable syringe production
BD (Becton, Dickinson and Company) has announced a $110m investment to expand its production of prefillable syringes in the ...
DUBLIN--(BUSINESS WIRE)--The "Prefilled Syringes - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Prefilled Syringes was estimated ...
The prefilled syringe is provided as a 300mg/2mL (150mg/mL) ready-to-use solution for subcutaneous injection and does not require additional reconstitution or dilution. Takhzyro ® (lanadelumab-flyo) ...
The new single-dose prefilled syringes will be available in 40 USP units/0.5mL and 80 USP units/mL dosage strengths. The Food and Drug Administration (FDA) has approved Purified Cortrophin ® Gel ...
Please provide your email address to receive an email when new articles are posted on . The European Medicines Agency approved the Vabysmo 6 mg prefilled syringe for three retinal conditions, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback